Evaluation of Volumetric Changes of Augmented Maxillary Sinus With Different Bone Grafting Biomaterials


Gultekin B. A. , Cansiz E., Borahan O. , Mangano C., Kolerman R., Mijiritsky E., ...More

JOURNAL OF CRANIOFACIAL SURGERY, vol.27, no.2, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.1097/scs.0000000000002393
  • Title of Journal : JOURNAL OF CRANIOFACIAL SURGERY
  • Keywords: Bone substitutes, cone beam computed tomography, sinus floor augmentation, volume change, FLOOR AUGMENTATION, AUTOGENOUS BONE, RADIOGRAPHIC EVALUATION, 3-DIMENSIONAL CHANGES, DIFFERENT RATIOS, FOLLOW-UP, BIO-OSS, ALLOGRAFT, ELEVATION, IMPLANTS

Abstract

Extensive alveolar bone resorption because of pneumatized maxillary sinus is a common problem that limits dental implant placement. Maxillary sinus floor augmentation (MSFA) is an accepted treatment protocol that provides sufficient bone volume. The aim of this study was to evaluate the percentage of graft volume reduction following MSFA using cone beam computed tomography. In this retrospective study, cone beam computed tomography scans of MSFA were measured to evaluate the volume of the grafted sinus with deproteinized bovine bone (DBB), mineralized allograft (MA), or a mixture of MA and demineralized allograft as a composite. The volumetric changes in sinus augmentation between 2 weeks (T-I) and 6 months (T-II) after operation were analyzed. Thirty-nine patients were included in this study. The average percent volume reduction was 8.14 +/- 3.76%, 19.38 +/- 9.22%, and 24.66 +/- 4.68% for DBB, MA, and composite graft, respectively. A significant graft volume reduction was found between T-I and T-II for all groups (P < 0.01). The DBB group showed the least volume reduction (P < 0.01). Biomaterials can influence the bone graft volume change before implant placement. Deproteinized bovine bone may offer greater volume stability during healing than mineralized and composite allografts.